A synthetic intermediate
Technical Support & Resources

Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

BI SF3 (hydrochloride)

Item No. 41113

Technical Information
Formal Name
5-chloro-1H-indazole-3-methanamine, monohydrochloride
CAS Number
1801257-24-8
Molecular Formula
C8H8ClN3 • HCl
Formula Weight
Purity
≥95%
A solid
DMSO: Sparingly soluble: 1-10 mg/mlEthanol: Slightly soluble: 0.1-1 mg/mlPBS (pH 7.2): Slightly soluble: 0.1-1 mg/ml
SMILES
NCC1=NNC2=C1C=C(Cl)C=C2.Cl
InChi Code
InChI=1S/C8H8ClN3.ClH/c9-5-1-2-7-6(3-5)8(4-10)12-11-7;/h1-3H,4,10H2,(H,11,12);1H
InChi Key
MPOSGKLUNWIIRB-UHFFFAOYSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Add

    Product Description

    BI SF3 is a synthetic intermediate.1 It has been used in the synthesis of quinolinyloxazoles with kallikrein inhibitory activity.

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. McDonald, A., and Qian, S. Therapeutic inhibitory compounds. (2018).